Seller record · Telehealth service
SkinnyRx
Fails 2 of 8 criteria. S3, pharmacy identification: The terms, privacy, questions and treatment pages each refer to a partner pharmacy or to 503A pharmacies as a category, and no facility is named. 1 more criterion also fails; see the table below.
At a glance
SkinnyRxTelehealth service
- Price
- First month from $99 (no later price printed)
- Sells
- compounded semaglutide injections and tablets, and 3 more
- FDA letters
- 1 on file
Partner link. The site earns a commission on care started through it. Funding
Visit SkinnyRxSee all eight dispositionsTelehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A telehealth service selling compounded semaglutide and tirzepatide as injections and tablets, alongside brand GLP-1 prescriptions. Its pages render only in a browser, and its address appears in the terms and the privacy policy rather than on its contact page.
Operating entity Lean Rx, Inc.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | SkinnyRx's contact page |
| S2 | Prescription gating | PASS | SkinnyRx's intake page |
| S3 | Pharmacy identification | FAIL | SkinnyRx's FAQ |
| S4 | Compounding disclosure | PASS | SkinnyRx's website |
| S5 | Analytical documentation | FAIL | SkinnyRx's semaglutide injectable product page |
| S6 | Business address | PASS | SkinnyRx's terms |
| S7 | Price disclosure | PASS | SkinnyRx's website |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide injections and tablets, compounded tirzepatide injections and tablets, Wegovy, Foundayo.
Other sellers of the same products
Enforcement documents on file: 1 warning letter
FDA warning letter 717989, issued February 2026, to Lean Rx, Inc. dba SkinnyRxClaims on SkinnyRx's website that compounded products give the same active ingredient as name-brand GLP-1 medications are false or misleading.
A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.
Partner link. The site earns a commission on care started through it. Funding.
Visit SkinnyRxDispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.